Literature DB >> 1742893

Squamous carcinoma of the posterior pharyngeal wall.

A S Jones1, P M Stell.   

Abstract

We present 70 patients with tumours of the posterior pharyngeal wall, considering tumours of the posterior hypopharyngeal and posterior oropharyngeal wall as one unit. Almost half (45%) of the patients were in poor general condition at the time of presentation, and 60% had Stage III or IV tumours. One-third of the patients were untreated, and surgery was mainly reserved for patients with Stage I and II tumours. The larynx could be preserved in two-thirds of those undergoing surgery. The best current method of repair of the posterior pharyngeal wall after partial pharyngectomy appears to be a revascularized radial forearm flap. The median survival for patients with Stage I tumours was 236 weeks, but for patients with Stages II-IV tumours was only 33 weeks. There was no significant difference between the survival for II-IV stage groups, but there was between Group I and the rest. We identify 2 defects in the UICC classification system: lack of definition of the lateral limit of the posterior pharyngeal wall, and a gross discrepancy between size and T staging of tumours arising primarily from the posterior wall of the hypopharynx.

Entities:  

Mesh:

Year:  1991        PMID: 1742893     DOI: 10.1111/j.1365-2273.1991.tb01040.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  3 in total

1.  Posterior pharyngeal wall carcinoma presenting as sudden onset bilateral upper limb radiculopathy.

Authors:  Swaroop Revannasiddaiah; Priyanka Thakur; Madhup Rastogi; Irappa Madabhavi; Adarshkumar Bellad; Sandeep Chindi
Journal:  BMJ Case Rep       Date:  2012-01-23

Review 2.  acp Best Practice No 169. Evidence based pathology: squamous carcinoma of the hypopharynx.

Authors:  T R Helliwell
Journal:  J Clin Pathol       Date:  2003-02       Impact factor: 3.411

Review 3.  [Pathological changes of the hypopharynx in the focus of imaging].

Authors:  S F Nemec; M Formanek; I M Noebauer-Huhmann; C R Krestan; J Frühwald; P Peloschek; A M Herneth; C Czerny
Journal:  Radiologe       Date:  2009-01       Impact factor: 0.635

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.